Full List Of Stories
Intel shares plummet after poor Q3 data centre sales
Intel's shares plummeted after the chip-making giant posted worse than expected sales for its data-center unit.
Europe close: Stocks push higher, UK lenders pace advance
European shares pushed ahead at the end of the week, helped by better-than-expected third quarter earnings from Britain’s Barclays bank and upbeat earnings news from continental car makers.
Week ahead: ECB, US tech giants' earnings in focus
The next-to-last week before the US Presidential elections will be heavily back-end loaded, with interest rate decisions from the European Central Bank and Bank of Japan both due out on Thursday, followed by quarterly earnings updates from Amazon, Apple and Facebook all due out after the close of trading that same day.
US business optimism surges in October, PMIs reveal
Most US corporates were in an unexpectedly buoyant mood in October, as reflected in the results of two closely-followed surveys.
AstraZeneca Covid-19 vaccine clinical trial readout may arrive in mid-November, Jefferies says
Analysts at Jefferies estimated that an initial read-out on AstraZeneca and Oxford University's ongoing late-stage trial of its Covid-19 vaccine might ready towards the middle of November.
FDA grants full approval to Gilead Sciences's Veklury for Covid-19
Gilead Sciences's antiviral Veklury, better known as Remdesivir, was given the stamp of the approval by the country's health watchdog overnight for use as a treatment against Covid-19.
Europe close: Stocks reverse early losses thanks to news on US stimulus
European shares finished the session little changed but well off their worst levels following reports pointing to higher odds of a near-term deal on a new fiscal stimulus package Stateside.